Franklin Gold & Prec Mtls A(acc)CHF-H1

Performance History31/03/2024
Growth of 1,000 (EUR)
Franklin Gold & Prec Mtls A(acc)CHF-H1
Fund39.5-2.7-22.92.1-3.9
+/-Cat-----
+/-Idx-----
 
Key Stats
NAV
25/04/2024
 CHF 3.78
Day Change 2.23%
Morningstar Category™ Other Equity
ISIN LU0536403115
Fund Size (Mil)
31/03/2024
 USD 401.13
Share Class Size (Mil)
25/04/2024
 CHF 1.04
Max Initial Charge 5.75%
Ongoing Charge
04/03/2024
  1.83%
Investment Objective: Franklin Gold & Prec Mtls A(acc)CHF-H1
The Fund’s principal investment objective is capital appreciation. Its secondary objective is income.
Returns
Trailing Returns (EUR)25/04/2024
YTD3.18
3 Years Annualised-7.03
5 Years Annualised10.38
10 Years Annualised1.03
12 Month Yield 0.00
Management
Manager Name
Start Date
Steve Land
30/04/2010
Frederick Fromm
30/04/2010
Inception Date
30/09/2010
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
FTSE Gold Mines TR USD-
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeYes
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  Franklin Gold & Prec Mtls A(acc)CHF-H131/03/2024
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks98.770.0098.77
Bonds0.000.000.00
Cash1.260.041.22
Other0.000.000.00
Top 5 Regions%
Canada57.22
Australasia23.98
United States6.93
Africa6.60
United Kingdom4.60
Top 5 Sectors%
Basic Materials99.69
Technology0.24
Industrials0.05
Utilities0.01
Top 5 HoldingsSector%
Agnico Eagle Mines LtdBasic MaterialsBasic Materials4.87
Alamos Gold Inc Class ABasic MaterialsBasic Materials4.39
Barrick Gold CorpBasic MaterialsBasic Materials4.05
Red 5 LtdBasic MaterialsBasic Materials3.96
Perseus Mining LtdBasic MaterialsBasic Materials3.90
Franklin Gold & Prec Mtls A(acc)CHF-H1
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookie Settings        Disclosures